脑动静脉畸形破裂出血的危险因素分析

doi:10.3969/j.issn.1000-8535.2019.03.009

广州医药 ›› 2019, Vol. 50 ›› Issue (3): 33-36.DOI: 10.3969/j.issn.1000-8535.2019.03.009

脑动静脉畸形破裂出血的危险因素分析

刘晓平, 叶敏, 张文波, 谢锋, 赖湘, 张光宇

梅州市人民医院(梅州 514031)

收稿日期:2019-01-13 出版日期:2019-05-20 发布日期:2021-12-17

Risk factors related to cerebral arteriovenous malformation with hemorrhage

LIU Xiaoping, YE Min, ZHANG Wenbo, XIE Feng, LAI Xiang, ZHANG Guangyu

Meizhou People's Hospotal, Meizhou 514031, China

Received:2019-01-13 Online:2019-05-20 Published:2021-12-17

摘要/Abstract

摘要： 目的探讨脑动静脉畸形(AVM)破裂出血发生的危险因素。方法回顾性研究2014年—2018年我院收治的AVM病例42例,根据有无破裂出血,分为出血组和非出血组,对AVM破裂出血发生的相关因素进行统计学分析。结果通过相关性及逐步回归分析,表明AVM破裂出血的独立危险因素为: 深部静脉引流和低龄患者。结论对于引流静脉为深部静脉引流类型和低龄的AVM患者,应积极尽早治疗。

关键词: 脑动静脉畸形, 破裂出血, 危险因素

Abstract: Objective To analyze the risk factors related to cerebral arteriovenous malformation(AVM)with hemorrhage. Methods The clinical data of 42 patients with AVM between 2014 and 2018 were respectively studied. According to the presence of rupture, the cases were divided into bleeding group and non-bleeding group. The factors associated with the occurence of AVM rupture were statistically analyzed. Results The correlation and logistic regression analysis suggested that the deep venous drainage and young patients were the independent risk factors for AVM rupture. Conclusion The young patients and the patients with deep venous drainage should be operated as soon as possible to avoid hemorrhage.

Key words: Cerebral arteriovenous malformation, Rupture with hemorrhage, Risk factors

刘晓平, 叶敏, 张文波, 谢锋, 赖湘, 张光宇. 脑动静脉畸形破裂出血的危险因素分析[J]. 广州医药, 2019, 50(3): 33-36.

LIU Xiaoping, YE Min, ZHANG Wenbo, XIE Feng, LAI Xiang, ZHANG Guangyu. Risk factors related to cerebral arteriovenous malformation with hemorrhage[J]. Guangzhou Medical Journal, 2019, 50(3): 33-36.

参考文献

[1] AL-SHAHI R,PAL N, LEWIS S C, et al. Observer agreement in the angiographic assessment of arteriovenous malformations of the brain [J]. Stroke,2002,33(6): 1501-1508.
[2] KIM H AI-SHAHI S R, MCCULLOCH C E. Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors [J]. Neurol,2014,83(7): 590-597.
[3] MOHR J P, PARIDES M K, STAPF C. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations(ARUBA): a multicentre, non-blinded, randomized trial [J]. Lancet, 2014,383(9917): 614-621.
[4] GROSS B A,DU R. Natural history of cerebral arteriovenous malformations: a meta-analysis [J]. J Neurosurg,2013,118 (2): 437-443.
[5] PORRAS J L,YANG W,PHILADELPHIA E,et al. Hemorrhage risk of brain arteriovenous malformations during pregnancy and puerperium in a north american cohort [J]. Stroke,2017,48(6): 1507-1513.
[6] 郭鹏,赵继宗. 脑动静脉畸形 3094 例的临床特征及外科治疗效果分析 [J]. 中华医学杂志,2011,91(39): 2740-2743.
[7] YAMADA S,TAKAGI Y,NOZAKI K,et al. Risk factors forsubsequent hemorrhage in patients with cerebral arteriovenous malformations [J]. J Neurosurg,2007,107(5): 965-972.
[8] STAPF C,MAST H,SCIACCA R R,et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation [J]. Neurol,2006,66(9): 1350-1355.
[9] BURKHARDT J K, CHEN X, WINKLER E A, et al. Delayed venousdrainage in ruptured arteriovenous malformations based on quantitative color-coded digital subtraction angiography [J]. World Neurosurg, 2017,104(8): 619-627.
[10] 王志刚, 张纪庆, 等. 脑动静脉畸形出血的血管构筑学因素探讨 [J]. 山东大学学报(医学版), 2007, 45(4): 389-392.
[11] HEINTEL T M, BERGLEHNER A, MEFFERT R. Accuracy of percutaneous pedicle screws for thoracic and lumbar spine fractures: aprospetive trial [J]. Eur Spine J,2013,22(3): 495-502.
[12] KUBALEK R,MOGHTADERI A,KLISCH J. Cerebral arteriovenous malformations: influence of angioarchitecture on bleeding risk [J]. Acta Neurochir,2003,145(12): 1045-1052.
[13] STAPF C,MOHR J P,PILE-SPELLMAN J,et al. Concurrent arterial aneurysms in brain arteriovenous malformations with haemorrhagic presentation [J]. J Neurol Neurosurg Psychiatry,2002,73(3): 294-298.
[14] DING D. Pathogenesis of radiosurgery-induced cyst formation in patients with cerebral arteriovenous malformations [J]. Acta Neurchir(Wien),2015,157(5): 775-777.

[1]	许怡文, 李清初. 糖尿病肾病患者肾功能恶化进展的危险因素[J]. 广州医药, 2021, 52(5): 40-43.
[2]	陈冬妮, 吴维涛, 肖小华, 肖孝勇, 曾鸣, 崔曼丽, 杜新. 老年急性缺血性脑卒中并发肺部感染的危险因素[J]. 广州医药, 2021, 52(3): 28-31.
[3]	罗水妹, 黄颂平, 许白兰, 沈冰寒. 肺癌并发肺栓塞的危险因素及预后分析[J]. 广州医药, 2021, 52(2): 40-45.
[4]	赵稳, 王延生, 周霞, 王小凡, 吴德阳, 熊淑琪, 徐军, 刘明. 肺纤维化急性加重患者短期内死亡危险因素分析[J]. 广州医药, 2020, 51(5): 1-4.
[5]	朱艳霞, 钟雄东. 剖宫产术后切口脂肪液化危险因素Logistic回归分析[J]. 广州医药, 2020, 51(3): 102-106.
[6]	余显畅, 钟雄东. Milligan-Morgan术后出现胃肠道症状危险因素Logistic回归分析[J]. 广州医药, 2020, 51(2): 81-84.
[7]	陈巧聪, 楼慧玲, 彭程, 袁辉辉. FRAX^®评估广州社区中老年人群骨折风险的回顾性研究[J]. 广州医药, 2019, 50(3): 18-22.
[8]	陈泳华, 曾军, 刘春丽, 王健. COPD合并肺动脉高压疾病危险因素分析[J]. 广州医药, 2018, 49(5): 74-77.
[9]	黎婉红, 蔡邦, 莫鉴文, 胡永成, 王振英, 陈国锋. 鼻咽癌放疗后鼻窦炎临床特征及其影响因素的Logistic分析[J]. 广州医药, 2018, 49(5): 24-28.
[10]	巫泓生, 廖碧玲, 王健, 陈浩, 林波, 曹天生. 外科Ⅲ类手术切口术后感染危险因素Logistic回归分析[J]. 广州医药, 2018, 49(2): 76-79.
[11]	温文星, 邓永上, 黎先祥, 周卓, 罗伟东. 断指再植术后发生血管危象的危险因素分析[J]. 广州医药, 2017, 48(5): 75-77.
[12]	何英俊. 肺结核发病的危险因素病例对照研究[J]. 广州医药, 2017, 48(5): 89-92.
[13]	钟承华, 张建华, 林洪胜, 陈厚赏, 陈贵俦. 胸部良性疾病非计划性二次手术临床分析与探讨[J]. 广州医药, 2016, 47(6): 39-41.
[14]	卢春如, 谢楚莲, 魏伟泉. 4CH8健康管理模式对社区更年期女性冠心病危险因素的干预效果分析[J]. 广州医药, 2016, 47(5): 90-91.
[15]	张瑞辉, 宋文霞, 成明建, 黎婉红, 陈明弟, 林伟鹏. 对清洁手术围手术期抗菌药物不合理使用危险因素的logistic分析[J]. 广州医药, 2016, 47(3): 90-92.

脑动静脉畸形破裂出血的危险因素分析

Risk factors related to cerebral arteriovenous malformation with hemorrhage

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价